|
|||||
|
|
Fibroblast growth factor 23: associations with antiretroviral therapy in patients co‐infected with HIV and hepatitis C |
|
| Authors: | J Young I Mucsi KC Rollet‐Kurhajec MB Klein the Canadian Co‐infection Cohort |
| Affiliation: | 1. Department of Medicine, Division of Infectious Diseases/Chronic Viral Illness Service, McGill University Health Centre, Montreal, QC, Canada;2. Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital Basel, Basel, Switzerland;3. Department of Medicine, Division of Nephrology, McGill University Health Centre, Montreal, QC, Canada;4. Department of Medicine, Division of Nephrology, University Health Network, University of Toronto, Toronto, ON, Canada |
| Abstract: | |
| Keywords: | antiretroviral therapy fibroblast growth factor 23 hepatitis C HIV |